Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
buy vibrator.
Popular Articles

The Bazelon Center Welcomes President Obama's Pledge To People With Mental Disabilities On Olmstead's 10th Anniversary
The Bazelon Center for Mental Health Law welcomes President Obama"s announcement today of his commitment to the promise of the landmark Supreme Court case, Olmstead v. L.C., on its 10th anniversary. In a statement released by the White House today the President launched a "Year of Community Living" and tasked the Departments of Health and Human Services (HHS) and Housing and Urban Development (HUD) to identify initiatives that will develop and improve services and supports to assist people with disabilities who wish to live in the most integrated settings possible.
pharmacy online
Covidien Receives FDA Clearance For Its Puritan Bennett 840™ Ventilator System With New Automatic Leak Adjustments Software Option
Covidien (NYSE: COV), a leading global healthcare products company and recognized innovator in mechanical ventilation and respiratory care devices, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Leak Compensation software feature for the Puritan Bennett 840™ ventilator system. This option provides continuous levels of mechanical ventilation to patients requiring respiratory support, regardless of the level of gas leakage that might occur in the circuit or past a patient interface device in the clinical setting.
News of the day
Multimodality Treatments Effective In Halting Lung Cancer Progression
The world"s top lung cancer specialists, medical professionals and researchers are convening this week in San Francisco, CA for the 13th World Conference on Lung Cancer (WCLC), organized by the International Association for the Study of Lung Cancer (IASLC). As non-small cell lung cancer (NSCLC) is one of the most common types of lung cancer affecting a heterogeneous population, researchers have focused on multi-modality treatment regimens to improve patient outcomes. According to research showcased today at the WCLC, multi-modality, tailored treatment regimens increased patient survival rates compared to single-agent therapies.
Oncology

Conference: Discovery Partnerships: Academia & Industrial Interactions

Opal Events is proud to present our next exciting conference Drug Discovery Partnerships: Academia & Industrial Interactions , to be held at the Hyatt Regency in Boston on October 28-30, 2009. Early stage drug discovery is a key bottleneck in the pipeline to find novel drugs. With key products suffering patent expiration in coming years, the need for new approaches to accelerate development of new chemical entities to treat severely unmet medical needs is more urgent than ever. This event brings together pharmaceutical companies, universities, small biotechnology enterprises, government agencies, for-profit and not-for profit research institutions to exchange ideas, make connections and discuss opportunities to create an environment that will foster pharmaceutical innovation. Overcome Your Most Critical Challenges in forming Academia-Industrial Partnerships: - Understand Specific Requirements Regarding Investigational New Drug (IND) Application and Approval Process - Maximize the Value and Minimize the Risk by Partnering with the Right Entity - Hear Insider"s Guide to Securing Grant Money for Your Drug Discovery Project - Examine Recent United States Decisions and their Impact on Pharmaceutical and Academia Patenting - Improve Speed to Market with Seamless Alignment on Science and Technology Who Will Attend? Pharmaceuticals, Biotechs, Academia, Foundations, Technology Companies and CRO"s - Managers/ Directors/ VP"s/ Faculty Advisors of: - External Research Collaboration - Scientific Affairs - Business Development - Partnership/ Alliance Management - Office of Technology Transfer - Academic Screening Facilities - School of Medicine/ Life Sciences/ Pharmacy - Grants Manager - Program Officer - Research & Development Sponsorship and Exhibiting Opportunities If you are interested in sponsorship, exhibiting or speaking opportunities, please contact Kay Ye at kye@opalevents.org or 212 532-9898, extension 263. Register Registration is already open on our website here. Sign up today! Opal Events


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009